Friday, September 18, 2015 5:39:33 PM
The 2012 FDA advisory committee voted 8 to 5 that ampligen is safe enough for commercialization. I think the large number of 200-400mg infusions show that it is well tolerated.
And more and more evidence that ampligen is a valuable drug for a variety of diseases. So maybe the FDA hates Carter because he was right? You've got to give him credit for hanging in there. We just need one more trial, using the NK cell data. It's clear HEB won't and cannot pay for a trial, so NIH will have to either cough up the cost or conditionally approve. Pressure is mounting.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM